Tackling Tumour Cell Heterogeneity at the Super-Resolution Level in Human Colorectal Cancer Tissue.
Fabian LangMaría F Contreras-GerenasMárton GellériJan NeumannOle KrögerFilip SadloKrzysztof BerniakAlexander MarxChristoph CremerHans-Achim WagenknechtHeike AllgayerPublished in: Cancers (2021)
Tumour cell heterogeneity, and its early individual diagnosis, is one of the most fundamental problems in cancer diagnosis and therapy. Single molecule localisation microscopy (SMLM) resolves subcellular features but has been limited to cultured cell lines only. Since nuclear chromatin architecture and microRNAs are critical in metastasis, we introduce a first-in-field approach for quantitative SMLM-analysis of chromatin nanostructure in individual cells in resected, routine-pathology colorectal carcinoma (CRC) patient tissue sections. Chromatin density profiles proved to differ for cells in normal and carcinoma colorectal tissues. In tumour sections, nuclear size and chromatin compaction percentages were significantly different in carcinoma versus normal epithelial and other cells of colorectal tissue. SMLM analysis in nuclei from normal colorectal tissue revealed abrupt changes in chromatin density profiles at the nanoscale, features not detected by conventional widefield microscopy. SMLM for microRNAs relevant for metastasis was achieved in colorectal cancer tissue at the nuclear level. Super-resolution microscopy with quantitative image evaluation algorithms provide powerful tools to analyse chromatin nanostructure and microRNAs of individual cells from normal and tumour tissue at the nanoscale. Our new perspectives improve the differential diagnosis of normal and (metastatically relevant) tumour cells at the single-cell level within the heterogeneity of primary tumours of patients.
Keyphrases
- single cell
- single molecule
- induced apoptosis
- gene expression
- cell cycle arrest
- dna damage
- transcription factor
- genome wide
- rna seq
- high resolution
- high throughput
- endothelial cells
- machine learning
- squamous cell carcinoma
- cell therapy
- stem cells
- mesenchymal stem cells
- dna methylation
- high speed
- oxidative stress
- newly diagnosed
- ejection fraction
- optical coherence tomography
- end stage renal disease
- prognostic factors
- label free
- patient reported outcomes
- lymph node metastasis
- clinical practice
- squamous cell